Pew Funds 10 Latin American Scientists Conducting Biomedical Research

2024-06-18
PHILADELPHIA, June 18, 2024 /PRNewswire/ -- The Pew Charitable Trusts today announced the 2024 class of the Pew Latin American Fellows Program in the Biomedical Sciences.
The 10 postdoctoral fellows from six Latin American countries—Argentina, Brazil, Chile, Cuba, Mexico, and Peru—will receive two years of funding to conduct research in laboratories across the United States. They will work under the mentorship of prominent biomedical scientists, including alumni from the Latin American fellows program and the Pew Scholars Program in the Biomedical Sciences.
"The grave threats to human health over the past few years—from COVID-19 to growing rates of cancer in younger adults—underscore how important it is to invest in promising biomedical scientists throughout the world," said Donna Frisby-Greenwood, Pew's senior vice president for Philadelphia and scientific advancement. "These outstanding Latin American researchers are poised to become leaders in the global scientific community, and Pew is proud to support them."
Fellows who choose to return to Latin America to launch their own research labs will receive additional funding from Pew. Approximately 68% of program participants have pursued this path, which has helped to build a more robust biomedical research community in Latin America.
Research interests in the 2024 class include exploring how mosquitoes detect human targets and transmit disease, engineering specialized RNA molecules to help ward off neurodegeneration, and investigating methods to activate a powerful anti-cancer protein that can prevent tumor growth.
"Biomedical research is a global effort, and collaborations that bring together different personal perspectives across scientific disciplines are key to making meaningful change," said Eva Nogales, Ph.D., distinguished professor in the Department of Molecular and Cell Biology at the University of California, Berkeley, and chair of the program's national advisory committee. "I'm thrilled to welcome this year's class, a group of exceptional Latin American scientists with immense talent. Their research in top labs will help pave the way for scientific discovery that can benefit human health across the globe."
The 2024 Pew Latin American fellows and their U.S. mentors are:
Nagif Alata Jimenez, Ph.D.
Laboratory of Marcos Simoes-Costa, Ph.D., 2008 Pew Latin American fellow
Nagif Alata Jimenez, Ph.D., will investigate the molecular programs that guide the formation of specialized cells during embryonic development.
Krist Antunes Fernandes, Ph.D.
Laboratory of Ai Ing Lim, Ph.D.
Krist Antunes Fernandes, Ph.D., will study how eradication of parasitic infections has shaped the immune system, especially during pregnancy, and fostered the development of asthma and respiratory infections.
Carolina Cabalín, Ph.D.
Laboratory of Niroshana Anandasabapathy, M.D., Ph.D.
Carolina Cabalín, Ph.D., will explore how cancer-targeted drugs that stimulate immunity can trigger autoimmune disorders such as the skin condition vitiligo.
Florencia Fernandez-Chiappe, Ph.D.
Laboratory of Meg Younger, Ph.D., 2024 Pew biomedical scholar
Florencia Fernandez-Chiappe, Ph.D., will assess how the unusual structure of a mosquito's olfactory system allows it to detect a human's signature scent.
Jovanka Gencel-Augusto, Ph.D.
Laboratory of Jennifer R. Grandis, M.D.
Jovanka Gencel-Augusto, Ph.D., will determine alternative strategies to activate p53, a protective protein that can be harnessed to defend against cancer.
Gladys Gutiérrez-Bugallo, Ph.D.
Laboratory of George Dimopoulos, Ph.D., MBA
Johns Hopkins University Bloomberg School of Public Health
Gladys Gutiérrez-Bugallo, Ph.D., will explore the factors that allow female mosquitoes to pass viruses to their progeny.
Mateo Alejandro Martínez-Roque, Ph.D.
Laboratory of Samie R. Jaffrey, M.D., Ph.D.
Mateo Alejandro Martínez-Roque, Ph.D., will pursue the development of "glue RNAs" that can be used to guide the degradation of abnormal proteins, which can lead to diseases such as amyotrophic lateral sclerosis.
Felipe Méndez-Salcido, Ph.D.
Laboratory of A. Kimberley McAllister, Ph.D., 2001 Pew biomedical scholar
Felipe Méndez-Salcido, Ph.D., will explore how dysregulation in dopamine signaling can drive the altered cognitive behaviors characteristic of schizophrenia.
Brenda Nakagaki, Ph.D.
Laboratory of Evanna Mills, Ph.D., 2024 Pew biomedical scholar
Brenda Nakagaki, Ph.D., will investigate how the metabolic dysfunction that accompanies diet-induced obesity triggers inflammation in different cells and tissues.
Guido Petrovich, Ph.D.
Laboratory of Josefina del Mármol, Ph.D., 2023 Pew biomedical scholar
Guido Petrovich, Ph.D., will dissect the molecular mechanisms by which the insects that transmit Chagas disease locate their human hosts.
Founded in 1948, The Pew Charitable Trusts uses data to make a difference. Pew addresses the challenges of a changing world by illuminating issues, creating common ground, and advancing ambitious projects that lead to tangible progress.
Erin Davis, 202-540-6677, [email protected]
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
机构
[+8]
适应症
[+9]
靶点
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。